Pacific Biosciences People in the News at Pacific Biosciences, Metabolon, NeoGenomics, More Pacific Biosciences Partners with Japan's iLAC, RBI on Automated Sequencing Workflows The automated workflows will use the Robotic Biology Institute's LabDroid to support whole-genome sequencing, targeted sequencing, and RNA isoform sequencing. Genomic Study Reveals Recurrent Inversion Variants, Instability Effects Genomic data for 41 individuals representing 82 haplotypes helped unearth recurrent inversion polymorphisms, including variants overlapping with disease-related sites. Pacific Biosciences Makes Progress on Sequencer Development, Amends Invitae Deal Premium Invitae will no longer make payments during the R&D phase of the collaboration and instead will pay a higher price on the instrument and consumables later on. Pacific Biosciences Q1 Revenues Grow 14 Percent The Menlo Park, California-based sequencing technology firm beat the consensus Wall Street estimate on the top line but missed it on the bottom line. Apr 21, 2022 Children's Mercy Test Drives Addition of Methylation Calls on Pacific Biosciences' Long-Read WGS Premium Apr 4, 2022 Pacific Biosciences, Corteva Agriscience Collaborate on High-Throughput Sequencing Apr 1, 2022 Genomic Answers for Kids Project Advances Long-Read Sequencing for Rare Disease Testing Premium Mar 31, 2022 T2T Consortium Publishes Early Findings From Complete Human Genome Assembly Mar 31, 2022 At ABRF Meeting, T2T Consortium Describes Improvements of Complete Human Genome Mar 25, 2022 In Brief This Week: Pacific Biosciences, NGeneBio, Cue Health, Theradiag, More Mar 4, 2022 In Brief This Week: Pacific Biosciences, BioEcho, Twist Bioscience, Arrayjet, More Feb 24, 2022 Researchers Look to New Sequencing Methods to Settle Debate Over 6mA Modifications in Humans Premium Feb 16, 2022 Pacific Biosciences Plans Sequencing Updates, Enters New Collaborations Premium Feb 15, 2022 Pacific Biosciences Revenues Grow 33 Percent in Q4, 65 Percent in 2021 Feb 11, 2022 Genome in a Bottle Consortium Releases Benchmark Data for Challenging Medically Relevant Genes Premium Feb 1, 2022 Stocks of Genomics Tools and MDx Firms Hit Hard in January Sell-off Jan 27, 2022 Hamilton, Pacific Biosciences Partner on Automating DNA Sample Prep Jan 20, 2022 Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable Jan 14, 2022 People in the News: New Appointments at Helix, Pacific Biosciences, SomaLogic, More Jan 13, 2022 Pacific Biosciences Outlines Progress on Short-Read Sequencing at JPM, Partners With Canexia Health Jan 11, 2022 PacBio Prelim Q4 Revenues up 33 Percent; Firm Partners With Google, Berry Genomics, Genomics England Jan 5, 2022 Pacific Biosciences, Care4Rare Canada Consortium Collaborate on Rare Disease Research Dec 10, 2021 Long Cell-Free DNA Molecules Could Provide New Target for Noninvasive Prenatal Testing Premium Dec 8, 2021 Pacific Biosciences, UCLA Collaborate on Rare Disease Diagnostics Load More Breaking News Canadian Healthcare Providers, Policymakers Value Different Aspects of Clinical Genomic Sequencing New Products Posted to GenomeWeb: Oxford Nanopore, Bio-Rad, NanoString, More People in the News at OraSure, Element Biosciences, Micronoma, More Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study The Scan Blend of Omicron With Delta The Associated Press reports that currently circulating Omicron variants have some features previously seen in the Delta variant. Limited Contrast The New York Times reports that there is a shortage of a contrast agent used for some medical scans. Pig Improvement Farmers in China are using genetics to improve their hog herds, according to Reuters. Science Papers Present Way to Molecularly Classify Prostate Cancer, Saliva-Based SARS-CoV-2 Test, More In Science this week: approach to molecularly classify prostate tumors, saliva-based test for SARS-CoV-2, and more.